Supplementary Figure from Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC

Julia Foldi, Adriana Kahn,Andrea Silber,Tao Qing,Emily Reisenbichler,Neal Fischbach,Justin Persico,Kerin Adelson,Anamika Katoch,Anees Chagpar,Tristen Park, Adam Blanchard,Kim Blenman,David L. Rimm,Lajos Pusztai

crossref（2023）

引用 0|浏览10

暂无评分

摘要

Supplementary Figure from Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要